找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Lentiviral Vectors and Gene Therapy; David Escors,Karine Breckpot,Holly Stephenson Book 2012 The Author(s) 2012 cancer.clinical trial.gene

[復制鏈接]
查看: 51607|回復: 37
樓主
發(fā)表于 2025-3-21 17:10:48 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Lentiviral Vectors and Gene Therapy
編輯David Escors,Karine Breckpot,Holly Stephenson
視頻videohttp://file.papertrans.cn/585/584970/584970.mp4
概述Concise overview of the development of lentivectors and gene therapy, integrating historical facts, the development and experimental application of lentivectors.Ideal introduction and book of referenc
叢書名稱SpringerBriefs in Biochemistry and Molecular Biology
圖書封面Titlebook: Lentiviral Vectors and Gene Therapy;  David Escors,Karine Breckpot,Holly Stephenson Book 2012 The Author(s) 2012 cancer.clinical trial.gene
描述.Gene therapy was conceived during the early and mid part of the 20th century. At first, it was considered a revolutionary biomedical procedure, which could potentially cure any disease for which the molecular bases were understood. Since then, gene therapy has gone through many stages and has evolved from a nearly unrealistic perspective to a real life application. Clinical efficacy in humans was demonstrated at the beginning of this century after its successful application in small-scale clinical trials to cure severe immunodeficiency in children. However, their successes were overshadowed some time later by the occurrence of vector-related leukaemia in a number of treated children. It is in this context that lentiviral vectors have appeared, with improved efficiency and, possibly, increased biosafety. Very recently, the first clinical trials with lentivectors have been carried out with some success. .This Brief firstly defines gene therapy, and places lentivectors within this fascinating therapeutic strategy. Then follows a comprehensive description of the development of retroviral and lentiviral vectors and how to specifically target distinct cell types and tissues. The authors
出版日期Book 2012
關鍵詞cancer; clinical trial; gene therapy; lentivector; promoter; viral immunology; genetic engineering
版次1
doihttps://doi.org/10.1007/978-3-0348-0402-8
isbn_softcover978-3-0348-0401-1
isbn_ebook978-3-0348-0402-8Series ISSN 2211-9353 Series E-ISSN 2211-9361
issn_series 2211-9353
copyrightThe Author(s) 2012
The information of publication is updating

書目名稱Lentiviral Vectors and Gene Therapy影響因子(影響力)




書目名稱Lentiviral Vectors and Gene Therapy影響因子(影響力)學科排名




書目名稱Lentiviral Vectors and Gene Therapy網絡公開度




書目名稱Lentiviral Vectors and Gene Therapy網絡公開度學科排名




書目名稱Lentiviral Vectors and Gene Therapy被引頻次




書目名稱Lentiviral Vectors and Gene Therapy被引頻次學科排名




書目名稱Lentiviral Vectors and Gene Therapy年度引用




書目名稱Lentiviral Vectors and Gene Therapy年度引用學科排名




書目名稱Lentiviral Vectors and Gene Therapy讀者反饋




書目名稱Lentiviral Vectors and Gene Therapy讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 22:51:56 | 只看該作者
David Escors,Grazyna Kochan,Holly Stephenson,Karine Breckpotanguage. In this paper, we explore the use of Boogie as an intermediate verification language for verifying programs in Whiley. This is noteworthy because the Whiley language has (amongst other things) a rich type system with considerable potential for an impedance mismatch. We report that, whilst a
板凳
發(fā)表于 2025-3-22 03:30:20 | 只看該作者
地板
發(fā)表于 2025-3-22 04:48:08 | 只看該作者
5#
發(fā)表于 2025-3-22 09:07:08 | 只看該作者
Grazyna Kochan,David Escors,Holly Stephenson,Karine Breckpotanguage. In this paper, we explore the use of Boogie as an intermediate verification language for verifying programs in Whiley. This is noteworthy because the Whiley language has (amongst other things) a rich type system with considerable potential for an impedance mismatch. We report that, whilst a
6#
發(fā)表于 2025-3-22 14:00:57 | 只看該作者
7#
發(fā)表于 2025-3-22 20:09:57 | 只看該作者
8#
發(fā)表于 2025-3-23 00:15:45 | 只看該作者
9#
發(fā)表于 2025-3-23 01:49:25 | 只看該作者
Immunomodulation by Genetic Modification Using Lentiviral Vectors,immunization strategies are needed, especially for chronic infections or malignant diseases where immune responses must be reactivated. Lentivector gene therapy can offer an alternative to modulate immune responses.
10#
發(fā)表于 2025-3-23 06:57:33 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-12 05:09
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
龙南县| 阳高县| 南召县| 金山区| 石楼县| 象州县| 兴山县| 山东| 德州市| 唐河县| 如皋市| 永和县| 江口县| 邯郸市| 弥渡县| 莱州市| 集安市| 寿阳县| 同心县| 云阳县| 梨树县| 清丰县| 伊春市| 剑阁县| 泽州县| 新宁县| 祥云县| 泾川县| 潍坊市| 乐安县| 安塞县| 阿拉善左旗| 邯郸县| 调兵山市| 玛沁县| 巴林左旗| 得荣县| 湘西| 平泉县| 林州市| 德阳市|